£50.0M
The financing round was co-led by Tencent and Flerie Invest to support Phase 1b clinical studies and pipeline expansion.
Microbiotica
Microbiotica develops microbiome-based therapeutics and precision biomarkers.
£50.0MTotal raised
Microbiotica discovers and develops microbiome-based therapeutics and biomarkers using a proprietary precision medicine platform. The company emerged from the Sanger Institute to advance live bacterial treatments across multiple disease areas.
Categories
Founders
MR
Mike Romanos
Co-Founder and CEO